Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMU62I8)

Drug Name
CX2009 Drug Info
Indication
Disease Entry ICD 11 Status REF
Neoplasm 2A00-2F9Z Phase 2 [1]
Solid tumour/cancer 2A00-2F9Z Phase 1/2 [2]
Cross-matching ID
TTD Drug ID
DMU62I8

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Activated leukocyte cell adhesionmolecule (ALCAM) TT2AFT6 CD166_HUMAN Not Available [3]

References

1 ClinicalTrials.gov (NCT04596150) Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of CytomX Therapeutics.